Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 261 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases.
DePalo DK, Dugan MM, Naqvi SMH, Ollila DW, Hieken TJ, Block MS, van Houdt WJ, Wouters MWJM, Reijers SJM, Asher N, Broman KK, Duncan Z, Anderson M, Gyorki DE, Snow H, Held J, Farma JM, Vetto JT, Hui JYC, [...] Zager JS
Cancer, 10 Nov 2024
Cited by: 0 articles | PMID: 39522025
Add to export list
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors.
Jirovec E, Quixabeira DCA, Clubb JHA, Pakola SA, Kudling T, Arias V, Haybout L, Jalkanen K, Alanko T, Monberg T, Khammari A, Dreno B, Svane IM, Block MS, Adamo DA, Mäenpää J, Kistler C, Sorsa S, Hemminki O, [...] Hemminki A
J Exp Clin Cancer Res, 43(1):297, 06 Nov 2024
Cited by: 0 articles | PMID: 39506856 | PMCID: PMC11539705
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Neoadjuvant immunotherapy versus adjuvant chemotherapy in anorectal melanoma.
Sassun R, Sileo A, Ng JC, Violante T, Gomaa IA, Block MS, Perry WRG, McKenna NP, Rumer KK, Larson DW
Br J Surg, 111(11):znae269, 01 Oct 2024
Cited by: 0 articles | PMID: 39495829
Add to export list
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting.
Stoff R, Markovic SN, McWilliams RR, Kottschade LA, Montane HN, Dimou A, Dudek AZ, Tan W, Dronca RS, Seetharam M, Chen R, Block MS
Melanoma Res, 34(6):510-518, 30 Aug 2024
Cited by: 0 articles | PMID: 39207855 | PMCID: PMC11524625
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Three Factors for Long-Term Dental Implant Success: Up to 40-year Follow-up.
Block MS
Oral Maxillofac Surg Clin North Am, S1042-3699(24)00059-1, 06 Sep 2024
Cited by: 0 articles | PMID: 39244494
Add to export list Review
Acceptance of SARS-CoV-2 Surveillance Testing Among Patients Receiving Dialysis: A Cluster Randomized Trial.
Montez-Rath M, Varkila M, Yu X, Brillhart S, Morgan C, Leppink A, Block MS, Mehta S, Hunsader P, Fountaine A, Subramanian N, Dittrich M, Owens DK, Chertow GM, Parsonnet J, Anand S, Block GA
JAMA Netw Open, 7(9):e2434159, 03 Sep 2024
Cited by: 0 articles | PMID: 39298171 | PMCID: PMC11413714
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Treatment outcomes of vulvar and vaginal melanoma at an NCCN institution between 1993 and 2021.
Ostby SA, Daniel S, Kalogera E, De Vitis L, Fought AJ, McGree ME, Langstraat CL, Block MS
Gynecol Oncol Rep, 55:101483, 13 Aug 2024
Cited by: 0 articles | PMID: 39247489 | PMCID: PMC11379566
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial.
Gupta A, O'Cearbhaill RE, Block MS, Hamilton E, Konner JA, Knutson KL, Potts J, Garrett G, Kenney RT, Wenham RM, TPIV200 Ovarian Cancer Study Investigators (listed at the end)
Gynecol Oncol, 189:90-97, 27 Jul 2024
Cited by: 0 articles | PMID: 39068739
Add to export list
A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.
Kalogera E, Nevala WK, Finnes HD, Suman VJ, Schimke JM, Strand CA, Kottschade LA, Kudgus RA, Buhrow SA, Becher LR, Geng L, Glaser GE, Grudem ME, Jatoi A, Klampe CM, Kumar A, Langstraat CL, McWilliams RR, Wahner Hendrickson AE, [...] Block MS
Clin Cancer Res, 30(12):2623-2635, 01 Jun 2024
Cited by: 1 article | PMID: 38530846
Add to export list
What Factors May Influence a Clinician's Choice for an Implant System for Their Patients?
Block MS
J Oral Maxillofac Surg, 82(9):1088-1099, 28 May 2024
Cited by: 0 articles | PMID: 38876147
Add to export list
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A, Kournoutas I, Orme JJ, Block MS, Lucchinetti CF, Mustafa R, Flanagan EP
Neurol Neuroimmunol Neuroinflamm, 11(4):e200249, 02 May 2024
Cited by: 0 articles | PMID: 38696737 | PMCID: PMC11068306
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
REPLY: Transitioning From Teeth to Implants: A Narrative Review.
Block MS
J Oral Maxillofac Surg, 82(5):516, 01 May 2024
Cited by: 0 articles | PMID: 38697690
Add to export list
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
Gien LT, Enserro DM, Block MS, Waggoner S, Duska LR, Wahner-Hendrickson AE, Thaker PH, Backes F, Kidd M, Muller CY, DiSilvestro PA, Covens A, Gershenson DM, Moore KN, Aghajanian C, Coleman RL
Gynecol Oncol, 186:61-68, 10 Apr 2024
Cited by: 0 articles | PMID: 38603953
Add to export list
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Swift IJ, Rademakers R, Finch N, Baker M, Ghidoni R, Benussi L, Binetti G, Rossi G, Synofzik M, Wilke C, Mengel D, Graff C, Takada LT, Sánchez-Valle R, Antonell A, Galimberti D, Fenoglio C, Serpente M, Arcaro M, [...] Rohrer JD
Alzheimers Res Ther, 16(1):66, 28 Mar 2024
Cited by: 2 articles | PMID: 38539243 | PMCID: PMC10976725
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing.
Barman H, Venkateswaran S, Santo AD, Yoo U, Silvert E, Rao K, Raghunathan B, Kottschade LA, Block MS, Chandler GS, Zalis J, Wagner TE, Mohindra R
JCO Clin Cancer Inform, 8:e2300151, 01 Apr 2024
Cited by: 0 articles | PMID: 38687915
Add to export list
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
Hieken TJ, Nelson GD, Flotte TJ, Grewal EP, Chen J, McWilliams RR, Kottschade LA, Yang L, Domingo-Musibay E, Dronca RS, Yan Y, Markovic SN, Dimou A, Montane HN, Erskine CL, Piltin MA, Price DL, Khariwala SS, Hui J, [...] Block MS
Nat Commun, 15(1):1430, 16 Feb 2024
Cited by: 1 article | PMID: 38365756 | PMCID: PMC10873383
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
Sener U, Webb M, Breen WG, Neth BJ, Laack NN, Routman D, Brown PD, Mahajan A, Frechette K, Dudek AZ, Markovic SN, Block MS, McWilliams RR, Dimou A, Kottschade LA, Montane HN, Kizilbash SH, Campian JL
J Immunother Precis Oncol, 7(1):1-6, 05 Feb 2024
Cited by: 1 article | PMID: 38327758 | PMCID: PMC10846635
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Transitioning From Teeth to Implants: A Narrative Review.
Block MS
J Oral Maxillofac Surg, 82(4):468-477, 20 Jan 2024
Cited by: 0 articles | PMID: 38336353
Add to export list Review
Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 Infection.
Pathakumari B, Marty PK, Shah M, Van Keulen VP, Erskine CL, Block MS, Arias-Sanchez P, Escalante P, Peikert T
J Clin Med, 12(22):7136, 16 Nov 2023
Cited by: 0 articles | PMID: 38002748 | PMCID: PMC10672050
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Smith KER, Peng KW, Pulido JS, Weisbrod AJ, Strand CA, Allred JB, Newsom AN, Zhang L, Packiriswamy N, Kottke T, Tonne JM, Moore M, Montane HN, Kottschade LA, McWilliams RR, Dudek AZ, Yan Y, Dimou A, Markovic SN, [...] Block MS
Front Immunol, 14:1279387, 31 Oct 2023
Cited by: 3 articles | PMID: 38022659 | PMCID: PMC10644866
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 Infection
Pathakumari B, Marty PK, Shah M, Van Keulen VP, Erskine CL, Block MS, Arias-Sanchez P, Escalante P, Peikert T
Preprints.org, 09 Oct 2023
Cited by: 0 articles | PPR: PPR742213
Add to export list Preprint v1
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.
Luo Y, Shreeder B, Jenkins JW, Shi H, Lamichhane P, Zhou K, Bahr DA, Kurian S, Jones KA, Daum JI, Dutta N, Necela BM, Cannon MJ, Block MS, Knutson KL
J Immunother Cancer, 11(11):e007661, 01 Nov 2023
Cited by: 5 articles | PMID: 37918918 | PMCID: PMC10626769
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Impacted Maxillary Canine in the Adult: A Narrative Review and Implant Treatment Options.
Hartman MJ, Block MS
J Oral Maxillofac Surg, 82(1):65-72, 21 Sep 2023
Cited by: 0 articles | PMID: 37832597
Add to export list Review
Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 Infection
Marty PK, Pathakumari B, Shah M, Keulen VP, Erskine CL, Block MS, Arias-Sanchez P, Escalante P, Peikert T
Research Square, 24 Aug 2023
Cited by: 0 articles | PPR: PPR709568
Add to export list Preprint v1
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction.
Ray U, Thirusangu P, Jin L, Xiao Y, Pathoulas CL, Staub J, Erskine CL, Dredge K, Hammond E, Block MS, Kaufmann SH, Bakkum-Gamez JN, Shridhar V
Oncogene, 42(37):2725-2736, 07 Aug 2023
Cited by: 1 article | PMID: 37550562 | PMCID: PMC10491494
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 261 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding